Associated Papers
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine.
Zhou Y et al.
Science Advances, 2021
34516913 (PubMed )
Supplement: sciadv.abi6856_tables_s1_to_s8.zip › sciadv.abi6856_Table_S4.xlsx › Sheet1
Potent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine Kinase.
Coulibaly ST et al.
Plos One, 2015
Redesigning human 2'-deoxycytidine kinase enantioselectivity for L-nucleoside analogues as reporters in positron emission tomography.
Muthu P et al.
Acs Chemical Biology, 2014
Deoxycytidine kinase augments ATM-Mediated DNA repair and contributes to radiation resistance.
Bunimovich YL et al.
Plos One, 2014
Retrovolution: HIV-driven evolution of cellular genes and improvement of anticancer drug activation.
Rossolillo P et al.
Plos Genetics, 2012
Select a paper to view details